Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.66 +0.01 (+1.71%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Current Deferred Revenue (2013 - 2016)

Updated

Biodexa Pharmaceuticals (BDRX) posted Current Deferred Revenue of $7.93 million for the quarter ended Dec 31, 2016, up 574.0% from $1.18 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Current Deferred Revenue (2013 - 2016) Analysis & Trends

As of Dec 31, 2016, Biodexa Pharmaceuticals' Current Deferred Revenue came in at $8.65 million, up 629.9% from the prior year.

  • Annual Current Deferred Revenue shows a three-year compound annual growth rate of 235.0% (years ended Dec 2013 to Dec 2016).
  • In prior years, Biodexa Pharmaceuticals' Current Deferred Revenue was $1.19 million in the year ended Dec 31, 2015, $41,200 in the year ended Dec 31, 2014 (-82.1%) and $230,030 in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 7.93 Mn
Dec 31, 2015 1.18 Mn
Dec 31, 2014 39,610.08
Dec 31, 2013 238,003.77
API Access

Biodexa Pharmaceuticals Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BDRX&period=max&api_key=YOUR_API_KEY